Active, Not Recruiting
Safety, Tolerability, and Immunogenicity of VAX-31 in Adults ≥50 Years With Immunobridging to Adults 18-49
NCT07284654
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +8 more
- Locations
-
- Accel Research Site - Achieve - Birmingham - ERN Birmingham, Alabama, United States
- Center for Indigenous Health - Chinle - Johns Hopkins Project Chinle, Arizona, United States
- Center for Indigineous Health - Whiteriver - John Hopkins Project Whiteriver, Arizona, United States
- Clinical Innovations Trials - Riverside - CenExel Riverside, California, United States